Marta Crispens
Faculty Member
Last active: 3/10/2014

  1. Uterine neoplasms, version 1.2014. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, Dupont N, Eifel PJ, Fader AN, Fisher CM, Gaffney DK, George S, Han E, Huh WK, Lurain JR, Martin L, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Tillmanns T, Valea FA, McMillian N, Hughes M (2014) J Natl Compr Canc Netw 12(2): 248-80
    › Primary publication · 24586086 (PubMed)
  2. TR3 modulates platinum resistance in ovarian cancer. Wilson AJ, Liu AY, Roland J, Adebayo OB, Fletcher SA, Slaughter JC, Saskowski J, Crispens MA, Jones HW, James S, Fadare O, Khabele D (2013) Cancer Res 73(15): 4758-69
    › Primary publication · 23720056 (PubMed) · PMC3944084 (PubMed Central)
  3. The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium. Fadare O, Gwin K, Desouki MM, Crispens MA, Jones HW, Khabele D, Liang SX, Zheng W, Mohammed K, Hecht JL, Parkash V (2013) Mod Pathol 26(8): 1101-10
    › Primary publication · 23524907 (PubMed) · PMC3886836 (PubMed Central)
  4. Ovarian cancer, version 2.2013. Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Chen LM, Copeland L, Crispens MA, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Powell MA, Remmenga SW, Sabbatini P, Santoso JT, Schink JC, Teng N, Werner TL, Dwyer MA, Hughes M, National comprehensive cancer networks (2013) J Natl Compr Canc Netw 11(10): 1199-209
    › Primary publication · 24142821 (PubMed)
  5. Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases. Fadare O, Zheng W, Crispens MA, Jones HW, Khabele D, Gwin K, Liang SX, Mohammed K, Desouki MM, Parkash V, Hecht JL (2013) Am J Cancer Res 3(1): 70-95
    › Primary publication · 23359866 (PubMed) · PMC3555196 (PubMed Central)
  6. Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance. Fadare O, Liang SX, Crispens MA, Jones HW, Khabele D, Gwin K, Zheng W, Mohammed K, Parkash V, Hecht JL, Desouki MM (2013) Hum Pathol 44(8): 1508-15
    › Primary publication · 23465280 (PubMed) · PMC3888088 (PubMed Central)
  7. Conventional endometrioid adenocarcinomas of the endometrium recurring as clear cell tumors: comparative immunohistochemical analyses. Rawish KR, Desouki MM, Crispens MA, Fadare O (2013) Ann Diagn Pathol 17(3): 270-5
    › Primary publication · 23394889 (PubMed)
  8. Composite uterine neoplasm with embryonal rhabdomyosarcoma and primitive neuroectodermal tumor components: rhabdomyosarcoma with divergent differentiation, variant of primitive neuroectodermal tumor, or unique entity? Cate F, Bridge JA, Crispens MA, Keedy VL, Troutman A, Coffin CM, Fadare O (2013) Hum Pathol 44(4): 656-63
    › Primary publication · 23266445 (PubMed)
  9. Cervical cancer. Koh WJ, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Giuntoli RL, Han E, Huh WK, Lurain JR, Martin L, Morgan MA, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Tillmanns T, Valea FA, McMillian NR, Hughes M, National Comprehensive Cancer Network (2013) J Natl Compr Canc Netw 11(3): 320-43
    › Primary publication · 23486458 (PubMed)
  10. Ovarian cancer, version 3.2012. Morgan RJ, Alvarez RD, Armstrong DK, Burger RA, Castells M, Chen LM, Copeland L, Crispens MA, Gershenson D, Gray H, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Remmenga SW, Sabbatini P, Santoso JT, Schilder RJ, Schink J, Teng N, Werner TL, Hughes M, Dwyer MA, National Comprehensive Cancer Network (2012) J Natl Compr Canc Netw 10(11): 1339-49
    › Primary publication · 23138163 (PubMed)